Can a Day 5 Morula Become a Blastocyst?

A day 5 morula can become a blastocyst, and most of them do. One study found that about 84% of day 5 morulae progressed to the blastocyst stage when given an additional 24 hours in culture, though larger datasets suggest the proportion that reach a quality high enough for freezing or transfer is considerably lower. The real question for anyone going through IVF is not just whether the transition happens, but what it means for the embryo’s genetic health, implantation potential, and the chances of a healthy pregnancy.

How Often Day 5 Morulae Actually Convert

The published conversion rates vary widely depending on how “blastocyst” is defined and what quality threshold a clinic uses. In a study tracking 256 day 5 morulae given an extra day of culture, 84.4% developed to the blastocyst stage. About 10% degenerated and roughly 6% arrested, staying stuck at the morula stage without progressing further.¹ That sounds encouraging, but those numbers capture any blastocyst formation at all, including embryos that expanded poorly or had low morphology grades.

A much larger retrospective study looking at over 5,000 day 5 morulae reported a blastulation rate of only 20.4%. Day 5 embryos that had already started cavitating (forming a small fluid-filled space, the first visible step toward becoming a blastocyst) fared better, converting at 39.2%.² The gap between these studies likely reflects different quality cutoffs: the smaller study counted every embryo that showed any blastocyst features, while the larger one likely applied stricter criteria for what counted as a usable blastocyst worth freezing or transferring.

A third dataset looked at slow-growing embryos (morulae and early blastocysts combined) that did not meet vitrification criteria on day 5. Among those, about 46% progressed to a full expanded blastocyst by day 6, but only 8% of those slow growers were ultimately good enough quality to freeze.³ So the honest answer is layered: most day 5 morulae will form some kind of blastocyst if you wait, but only a fraction will be high quality.

What Is Happening Inside the Embryo During This Transition

Before an embryo can become a blastocyst, its cells have to accomplish two things that do not happen automatically. First, compaction: the individual cells flatten against each other and bind tightly together using adhesion molecules, especially one called E-cadherin. This reorganization is not just cosmetic. The cells literally form stronger mechanical bonds at their contact points, and E-cadherin rearranges into a ring structure at the edges of each cell-cell junction.⁴ Calcium signaling inside the cells helps drive this process; when researchers experimentally disrupted calcium levels in mouse embryos, compaction reversed, and when calcium returned to normal, compaction resumed.⁵

Second, once the outer cells are sealed together tightly enough, they start pumping sodium ions through their membranes using a protein called Na/K-ATPase. This creates an osmotic gradient that draws water into the center of the embryo, inflating a fluid-filled cavity called the blastocoel.⁶ Recent work tracking sodium concentrations in real time confirmed this sequence: sodium drops inside the outer cells as it gets pumped into the cavity, water follows, and the embryo expands. When the pump is blocked with a drug called ouabain, sodium accumulates inside the cells and the cavity shrinks.⁷

A day 5 morula that has not yet started cavitating is an embryo that has either not finished compaction or has not yet begun active fluid transport. The biology is not broken; it is just behind schedule. Whether that delay matters depends on what is causing it.

What Causes the Delay

Several factors can slow an embryo’s progression from morula to blastocyst. The age of the egg provider is one of the strongest predictors. Among slow-growing embryos that did not meet freezing criteria on day 5, those from younger patients were more likely to catch up by day 6.³ That pattern shows up throughout the IVF literature: older eggs produce embryos that are more likely to stall at each developmental checkpoint.

The lab environment also plays a role. A comparison of two common culture systems found that the type of media used changed both the blastocyst formation rate and the rate of chromosomal abnormalities. Single-step media (one formulation from start to finish) produced a higher overall blastocyst rate than sequential media (different formulations for different stages), but also a higher aneuploidy rate. For women under 38, single-step media actually resulted in fewer chromosomally normal embryos per cycle despite making more blastocysts overall.⁸ This is a useful reminder that faster development in the dish is not always better, and slow development is not always the embryo’s fault.

Sperm source matters too. That same retrospective study found that cycles using surgically retrieved sperm were more likely to produce embryos that caught up from slow day 5 development to usable blastocysts on day 6.³ The reasons are not fully clear, but it may relate to differences in how fertilization was accomplished rather than inherent sperm quality.

Genetic Health of Blastocysts That Formed Late

One of the biggest concerns about slow embryos is whether the delay signals chromosomal problems. A systematic review and meta-analysis of frozen-thawed day 7 blastocyst transfers found that embryos reaching blastocyst stage that late had significantly lower rates of chromosomal normality (euploidy) compared to both day 5 and day 6 blastocysts.⁹ That does not mean every slow embryo is abnormal, but the odds shift.

The day 5 versus day 6 comparison is more nuanced and somewhat contested. One large study using next-generation sequencing found that day 5 blastocysts had meaningfully higher euploidy rates than day 6 blastocysts, with the gap reaching about 14 percentage points in embryos from the same stimulation cycle and about 20 points when comparing across different cycles.¹⁰ However, another retrospective study found no significant difference in overall aneuploidy rates between day 5 and day 6 embryos.¹¹ The discrepancy may come down to patient demographics, how embryos were selected for testing, or the size and composition of the study populations.

Time-lapse imaging has added another layer. Research tracking how well embryos compact at the morula stage found that incomplete compaction is a warning sign, especially for older patients. In women over 40, embryos that cleaved normally but only partially compacted had much higher aneuploidy rates than those that fully compacted. In younger women, the embryo seemed more capable of self-correcting early errors, so incomplete compaction was less predictive.¹² This suggests that the quality of compaction may matter as much as the timing.

How Delayed Blastulation Affects Pregnancy Outcomes

Even when a day 5 morula successfully becomes a blastocyst by day 6 or day 7, pregnancy rates tend to be lower than for embryos that hit blastocyst on time. The data on day 7 blastocysts is the most striking. One study comparing chromosomally normal (euploid) embryos by the day they reached blastocyst found live birth rates of about 69% for day 5, 55% for day 6, and 36% for day 7. The day 7 group was older on average, but even after age matching, the lower outcomes persisted.¹³

The meta-analysis mentioned earlier confirmed this pattern across multiple studies: day 7 blastocyst transfers were associated with roughly one-third to one-half the odds of clinical pregnancy and about one-fifth to one-third the odds of live birth compared to day 5 or day 6 transfers. Even when restricted to embryos that had been genetically screened and confirmed euploid, the disadvantage held.⁹ That last point is important: it means something about the embryo itself, beyond just chromosome count, is compromised by extreme developmental delay.

Despite the reduced odds, researchers and clinicians generally agree that day 7 blastocysts should not be discarded outright. The same meta-analysis explicitly noted that the findings “do not support the discharge of slow-blastulation embryos.”⁹ For patients with few embryos, a day 7 blastocyst still represents a real chance at pregnancy.

The Endometrial Synchrony Problem

Part of the outcome gap for late-developing embryos may not be the embryo’s fault at all. In a fresh IVF transfer, the uterine lining is preparing for an embryo on a schedule that assumes the embryo will be at blastocyst stage by day 5. If the embryo does not reach that stage until day 6 or later, the window when the lining is most receptive may have already started to close. A study of cryopreserved embryo transfers found evidence supporting this idea: the reduced success with later-developing blastocysts appeared to reflect a mismatch between embryo stage and endometrial receptivity rather than inherently worse embryo quality.¹⁴

This has practical implications. If the embryo is frozen as a day 6 blastocyst and transferred in a later cycle, the clinic can adjust the timing of progesterone administration to give the lining an extra day of preparation. A recent study compared transferring day 6 blastocysts on the equivalent of day 6 of progesterone versus day 7, and found no significant difference in clinical pregnancy rates (about 46% vs 42%) or early miscarriage rates between the two timing strategies.¹⁵ The takeaway is that freezing a late-developing blastocyst and transferring it in a subsequent cycle may partially compensate for the synchrony problem, because the clinic can tailor the lining’s preparation to match the embryo’s actual stage.

Timing of Compaction as a Predictor

Not all morulae are equal, and the speed at which an embryo compacts gives clinics useful information. Time-lapse imaging studies have shown that embryos reaching a compacted morula by about 95 hours post-fertilization and forming a regular blastocyst by about 114 hours were associated with significantly higher pregnancy rates than those missing either cutoff.¹⁶ A separate time-lapse study confirmed that embryos reaching the compaction milestones faster also tended to produce higher-quality blastocysts overall, with the time from morula to completed compaction differing by about four hours between the best and worst quality groups.¹⁷

For patients, this means the embryologist’s notes about compaction timing carry real prognostic weight. A day 5 morula that compacted early but is just a few hours behind on cavitation is a different story from one that compacted late and is struggling to catch up. Clinics with time-lapse incubators can track these milestones precisely, which helps them decide whether to keep culturing an embryo or whether it is unlikely to reach a usable stage.

Metabolic Differences Between Fast and Slow Embryos

The developmental pace of an embryo reflects genuine biological differences, not just random variation. Research comparing “fast” and “slow” blastocysts found that faster-developing embryos consumed significantly more of the amino acid aspartate and more glucose. They also expressed certain metabolic genes at higher levels, and these expression differences persisted even after transfer: placental tissue derived from fast embryos showed higher expression of the same metabolic genes, while fetal liver tissue showed a different pattern, with some of those genes expressed at lower levels.¹⁸

This finding is intriguing because it suggests that the tempo of early development is not just a short-lived trait. The metabolic profile an embryo establishes during its first few days may leave a lasting imprint on how the placenta and fetus develop. It is still early-stage research, mostly conducted in animal models, but it adds biological plausibility to the observation that developmental speed correlates with outcomes.

Are Babies Born from Day 6 Blastocysts Any Different

For patients who do get pregnant from a late-forming blastocyst, a natural worry is whether the baby will be smaller, larger, or otherwise affected by the embryo’s rocky start. A large retrospective analysis covering over 17,000 singleton births from frozen embryo transfers compared babies from day 5 and day 6 blastocysts. After adjusting for maternal age and other variables, there were no significant differences in the rates of being born small for gestational age, large for gestational age, low birth weight, or excessively high birth weight.¹⁹ Once a late-forming blastocyst successfully implants and leads to an ongoing pregnancy, the baby appears to grow normally.

This is reassuring, though the data mostly compares day 5 to day 6. There is less neonatal outcome data on day 7 blastocysts simply because so few transfers result in live births. What evidence exists has not raised red flags, but the sample sizes are too small to draw firm conclusions.

Emerging Tools for Assessing Slow Embryos

Clinics are starting to explore non-invasive ways to evaluate embryo potential beyond just looking at them under a microscope. One approach involves analyzing the spent culture medium that the embryo has been growing in, looking for tiny RNA molecules (microRNAs) that the embryo releases. Researchers identified several microRNAs whose levels in the culture medium differed between embryos that led to pregnancy and those that did not, measurable both at the cleavage stage on day 3 and at the blastocyst stage on day 5.²⁰ This kind of analysis could eventually help embryologists figure out which slow-developing embryos are worth continuing to culture and which are unlikely to produce a viable pregnancy, without needing to biopsy the embryo itself.

These tools are not yet standard clinical practice. Most clinics still rely on visual grading and, for those with time-lapse systems, the timing of developmental milestones. But for patients with only slow-developing embryos, future non-invasive biomarker tests could shift the decision from “discard or wait” to something more informed. The field is moving toward combining morphology, timing data, and molecular markers to give each embryo a more complete assessment, though making that practical at scale will take years of validation.